Neoadjuvant chemotherapy and nivolumab in resectable non-small-cell lung cancer (NADIM): an open-label, multicentre,…
Our results support the addition of neoadjuvant nivolumab to platinum-based chemotherapy
in patients with resectable stage IIIA NSCLC. Neoadjuvant chemoimmunotherapy could
change the perception of locally advanced lung cancer as a potentially lethal disease
to one that is curable.